1. Georgescu, Constantin, Corbin, Joshua M, Thibivilliers, Sandra, Wren, Jonathan D, Ruiz-Echevarría, Maria J. 2019. A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer. In BMC cancer, 19, 423. doi:10.1186/s12885-019-5592-6. https://pubmed.ncbi.nlm.nih.gov/31060542/
2. Gery, Sigal, Sawyers, Charles L, Agus, David B, Said, Jonathan W, Koeffler, H Phillip. . TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells. In Oncogene, 21, 4739-46. doi:. https://pubmed.ncbi.nlm.nih.gov/12101412/
3. Lee, Su Man, Park, Jae Yong, Kim, Dong Sun. 2012. Methylation of TMEFF2 gene in tissue and serum DNA from patients with non-small cell lung cancer. In Molecules and cells, 34, 171-6. doi:10.1007/s10059-012-0083-5. https://pubmed.ncbi.nlm.nih.gov/22814847/
4. Lin, Kui, Taylor, James R, Wu, Thomas D, de Sauvage, Frederic J, Meng, Y Gloria. 2011. TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in multiple cancer types including glioma. In PloS one, 6, e18608. doi:10.1371/journal.pone.0018608. https://pubmed.ncbi.nlm.nih.gov/21559523/
5. Huang, Hao, Teng, Peng, Mei, Ruyi, Zhao, Xiaofeng, Qiu, Mengsheng. 2017. Tmeff2 is expressed in differentiating oligodendrocytes but dispensable for their differentiation in vivo. In Scientific reports, 7, 337. doi:10.1038/s41598-017-00407-1. https://pubmed.ncbi.nlm.nih.gov/28336932/
6. Gao, Lingling, Nie, Xin, Zheng, Mingjun, Hao, Yingying, Lin, Bei. 2019. TMEFF2 is a novel prognosis signature and target for endometrial carcinoma. In Life sciences, 243, 116910. doi:10.1016/j.lfs.2019.116910. https://pubmed.ncbi.nlm.nih.gov/31610211/
智鼠故事 
